ACADIA Pharmaceuticals Inc.
ACAD
Peringkat dalam Saham
#4431
ACADIA Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily... ACADIA Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics. Their core focus lies in addressing critical unmet medical needs within the realm of central nervous system (CNS) disorders. The company's marketed product, NUPLAZID (pimavanserin), is prescribed for the management of hallucinations and delusions associated with Parkinson's disease psychosis. Beyond its commercialized offering, ACADIA maintains a robust development pipeline, featuring several promising candidates: Pimavanserin: This compound is currently undergoing Phase 3 clinical trials for additional indications, specifically for Alzheimer's disease psychosis and the negative symptoms of schizophrenia. Trofinetide: A novel synthetic compound, Trofinetide is also in Phase 3 development, aimed at treating Rett syndrome. ACP-044: This orally administered, first-in-class non-opioid analgesic is progressing through Phase 2 studies for both acute and chronic pain. ACP-319: Identified as a positive allosteric modulator of the muscarinic receptor, ACP-319 is in Phase 1 development, exploring its potential for schizophrenia and improving cognition in Alzheimer's patients. Established in 1993, ACADIA Pharmaceuticals Inc. is headquartered in San Diego, California.
Harga Saham
$20.39
Kapitalisasi Pasar
$3.51B
Perubahan (1 hari)
2.95%
Perubahan (1 tahun)
-2.65%
Negara
US
Perdagangan ACADIA Pharmaceuticals Inc. (ACAD)
Kategori
Healthcare
Riwayat pemecahan saham untuk ACADIA Pharmaceuticals Inc. (ACAD)
Saham ACADIA Pharmaceuticals Inc. (simbol: ACAD) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Oct 20, 2026.
Satu lembar saham ACAD yang dibeli sebelum Oct 20, 2026 sekarang setara dengan 0 lembar saham ACAD.
Pemecahan saham terbaru terjadi pada Oct 20, 2026.
Satu lembar saham ACAD yang dibeli sebelum Oct 20, 2026 sekarang setara dengan 0 lembar saham ACAD.
Daftar pemecahan saham
| Tahun | Pemecahan | Kelipatan | Kelipatan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | |||
Pemecahan saham untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pemecahan saham | Kelipatan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
